Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
about
Bacillus anthracis Inosine 5′-Monophosphate Dehydrogenase in Action: The First Bacterial Series of Structures of Phosphate Ion-, Substrate-, and Product-Bound ComplexesDe novo GTP Biosynthesis Is Critical for Virulence of the Fungal Pathogen Cryptococcus neoformansStructure ofPseudomonas aeruginosainosine 5′-monophosphate dehydrogenaseThe Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.Two classes of bacterial IMPDHs according to their quaternary structures and catalytic propertiesMycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular CompoundsThe antibiotic potential of prokaryotic IMP dehydrogenase inhibitorsRepurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.Helicobacter pylori relies primarily on the purine salvage pathway for purine nucleotide biosynthesisA novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.Structure of Cryptosporidium IMP dehydrogenase bound to an inhibitor with in vivo antiparasitic activity.Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α)(8) barrel enzymes.Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives.Inhibition of Inosine-5'-monophosphate Dehydrogenase from Bacillus anthracis: Mechanism Revealed by Pre-Steady-State Kinetics.A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open Access Malaria Box.
P2860
Q27670715-65C5E378-6FF6-43D8-8ECE-6FFF2B5850F4Q27674590-354A4A65-E9CD-4C58-93CB-AE4174C125DBQ27676976-6B0CEE88-2CB7-4CAA-ADC6-EDEAE33BB406Q27728459-6928A0A7-17B9-418F-A7B7-87017273B986Q28543579-A2CD4183-93DD-48F5-9ECE-AE995C6D3A5DQ28550069-AFB36EE7-1CD5-441E-A0CA-0AFB5BB808FBQ30356398-BA7FF1A6-47DF-4859-AFF9-EEB4F64B5F17Q30371392-B4446EC5-5435-4C93-B804-08C06E7D974BQ30425739-139937CC-029B-403F-9BE3-72556C1B9D5AQ35126722-721A1B56-BBE0-4C87-B981-B9AB0C550236Q35592527-4E33480C-5746-4387-85E2-A5F7CE852251Q37643702-3133F9C5-41A7-4A98-830C-878C99FF1BDBQ37983899-19B5C05F-2B80-459E-88A5-3C6BE54F16A7Q38558374-A3255C7C-21FC-4B0C-9FD1-AFDC8603B741Q41105047-CD48FA27-BA08-43E2-98C7-689CB0C1B348Q48022259-3F168EE3-FA1B-49BF-A1C4-35827FD5A1AA
P2860
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
@ast
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
@en
type
label
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
@ast
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
@en
prefLabel
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
@ast
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
@en
P2093
P2860
P1476
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
@en
P2093
Deviprasad R Gollapalli
Iain S Macpherson
Joanna B Goldberg
Lizbeth Hedstrom
Suresh Kumar Gorla
P2860
P304
P356
10.1016/J.CHEMBIOL.2010.07.014
P577
2010-10-01T00:00:00Z